
Please try another search
By Peter Nurse Investing.com - European stock markets traded higher Thursday, boosted by a slowing in the growth of German consumer prices while investors digested a flood of quarterly corporate...
By Geoffrey Smith Investing.com -- AstraZeneca (LON:AZN) stock slipped in morning trading in London on Monday, after the U.K.-Swedish pharma company said its Imfinzi drug had failed to reach primary...
By Scott Kanowsky Investing.com -- AstraZeneca PLC (LON:AZN) has signed a $320 million cash and debt deal to acquire bio-technology group Neogene Therapeutics, as the U.K. drugmaker looks to expand...
By Scott Kanowsky Investing.com -- AstraZeneca PLC (LON:AZN) has raised its guidance for full-year income per share, citing strong returns in its third quarter, but warned that the outlook may face a...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review